Buckeye Partners (BPL)

28.14 -0.03 (0.11%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/5/19 *Est.)

Latest Headlines

Buckeye (BPL) PT Lowered to $30 at Citi November 29, 2018 8:31 AM - StreetInsider Form 8-K BUCKEYE PARTNERS, L.P. For: Nov 28 November 29, 2018 6:05 AM - SEC Filing Form 4 BUCKEYE PARTNERS, L.P. For: Nov 12 Filed by: RUSSO TODD J November 14, 2018 4:25 PM - SEC Filing Form 8-K BUCKEYE PARTNERS, L.P. For: Nov 13 November 13, 2018 8:25 AM - SEC Filing Form 4 BUCKEYE PARTNERS, L.P. For: Nov 06 Filed by: Sauger Joseph November 7, 2018 11:32 AM - SEC Filing Buckeye (BPL) PT Lowered to $38 at Morgan Stanley November 7, 2018 7:55 AM - StreetInsider Form 8-K BUCKEYE PARTNERS, L.P. For: Nov 01 November 2, 2018 5:03 PM - SEC Filing Form 8-K BUCKEYE PARTNERS, L.P. For: Nov 02 November 2, 2018 4:39 PM - SEC Filing Form 10-Q BUCKEYE PARTNERS, L.P. For: Sep 30 November 2, 2018 4:30 PM - SEC Filing Swank Capital and Cushing® Asset Management Announce a Rebalance of The Cushing® MLP Market Cap Index November 2, 2018 11:25 AM - PR NewsWire Swank Capital and Cushing® Asset Management Announce a Constituent Change to The Cushing® MLP High Income Index November 2, 2018 11:22 AM - PR NewsWire Swank Capital and Cushing® Asset Management Announce a Constituent Change to The Cushing® 30 MLP Index November 2, 2018 11:03 AM - PR NewsWire SunTrust Robinson Humphrey Upgrades Buckeye (BPL) to Hold November 2, 2018 9:03 AM - StreetInsider Buckeye Partners (BPL) Reports Q2 Loss of $4.86/Share, Announces Outcome of Strategic Review November 2, 2018 6:37 AM - StreetInsider Buckeye Partners (BPL) Lowers Quarterly Dividend 40.6% to $0.75; 8.9% Yield November 2, 2018 6:37 AM - StreetInsider Buckeye Partners, L.P. Announces Outcome of Strategic Review November 2, 2018 6:30 AM - Globe NewsWire Buckeye Partners, L.P. to Release Earnings and Hold Conference Call for 2018 Third Quarter Financial Results October 26, 2018 4:37 PM - Globe NewsWire Credit Suisse Starts Buckeye (BPL) at Neutral October 10, 2018 4:13 PM - StreetInsider Research Report Identifies Ultragenyx Pharmaceutical, Helmerich & Payne, Buckeye Partners, Covanta Holding, Summit Midstream Partners, LP, and Seattle Genetics with Renewed Outlook — Fundamental October 3, 2018 7:50 AM - Globe NewsWire Full Article List